AGENT ELICITING ANTIHYPERLIPOPROTEINEMIC ACTIVITY, FOOD SUPPLEMENT BASED ON THEREOF AND METHOD OF TREATMENT OF LIPID METABOLISM DISTURBANCE IN PATIENTS WITH CARDIOVASCULAR DISEASES

FIELD: medicine, cardiology, pharmacology. SUBSTANCE: group of inventions comprises agent containing nicotinic acid and dried defibrinated blood of Siberian stag, Manchurian wapiti or sika deer taken in the following ratio of components, %: dried defibrinated Siberian stag blood, 99.0-1.0; nicotinic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GOL'DBERG E.D, DYGAJ A.M, UDUT V.V, POPOVA G.A, BORODULINA E.V, SUSLOV N.I, SHEBALIN A.I, GRIBOV S.A, FROLOV N.A
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine, cardiology, pharmacology. SUBSTANCE: group of inventions comprises agent containing nicotinic acid and dried defibrinated blood of Siberian stag, Manchurian wapiti or sika deer taken in the following ratio of components, %: dried defibrinated Siberian stag blood, 99.0-1.0; nicotinic acid, 1.0-99.0. Food supplement comprises nicotinic acid and dried defibrinated blood of Siberian stag, Manchurian wapiti or sika deer in the following ratio of components, %: defibrinated Siberian stag, 99.0-1.0; nicotinic acid, 1.0-99.0. Method of treatment involves prescription of dietotherapy of the proposed agent in the dose 1 capsule, 3 times per a day, for 21 days. Invention expands assortment of agents eliciting antihyperlipoproteinemic activity, enhancement of treatment effectiveness and reduction of adverse effects. EFFECT: enhanced effectiveness of supplement and treatment. 3 cl, 9 tbl